Encyclopedia of Medical Immunology

Living Edition
| Editors: Ian MacKay, Noel R. Rose

Immunodeficiency, Centromeric Instability, and Facial Dysmorphism (ICF Syndrome) (ICF1-DNMT3B, ICF-2 ZBTB24)

  • Vera GodaEmail author
Living reference work entry
DOI: https://doi.org/10.1007/978-1-4614-9209-2_187-1



Immunodeficiency-centromeric instability-facial anomalies syndrome (ICF) is a rare autosomal recessive (AR) primary immunodeficiency (PID) characterized by a profound hypogammaglobulinemia with characteristic rearrangements in the proximity of the centromeres of chromosomes 1, 16, and occasionally 9 in mitogen-stimulated lymphocytes. Other variable symptoms include characteristic facial dysmorphism, growth retardation, failure to thrive, and mental retardation. The main immunological defect is the lack of CD19+CD27+ memory B cells while B cells are usually present. Serum immunoglobulins are variably low. There are limited data on T-cell function; however, in reported cases T cell function is severely impaired. These patients suffer mainly from recurrent or chronic bacterial respiratory infections as presenting symptoms. Bronchiectasis, gastrointestinal and skin infections are also common from early childhood. According to the...

This is a preview of subscription content, log in to check access.


  1. Ehrlich M, Jackson K, Weemaes C. Immunodeficiency, centromeric region instability, facial anomalies syndrome (ICF). Orphanet J Rare Dis. 2006;1:2.  https://doi.org/10.1186/1750-1172-1-2.CrossRefPubMedPubMedCentralGoogle Scholar
  2. Hagleitner MM, Lankester A, Maraschio P, Hultén M, Fryns JP, Schuetz C, Gimelli G, Davies EG, Gennery A, Belohradsky BH, de Groot R, Gerritsen EJA, Mattina T, Howard PJ, Fasth A, Reisli I, Furthner D, Slatter MA, Cant AJ, Cazzola G, van Dijken PJ, van Deuren M, de Greef JC, van der Maarel SM, Weemaes CMR. Clinical spectrum of immunodeficiency, centromeric instability and facial dysmorphism (ICF syndrome). J Med Genet. 2008; 45:93–9.  https://doi.org/10.1136/jmg.2007.053397.CrossRefPubMedGoogle Scholar
  3. Maraschio P, Zuffardi O, Dalla Fior T, Tiepolo L. Immunodeficiency, centromeric heterochromatin instability of chromosomes 1, 9, and 16, and facial anomalies: the ICF syndrome. J Med Genet. 1988;25:173–80.CrossRefGoogle Scholar
  4. Sterlin D, Velasco G, Moshous D, Touzot F, Mahlaoui N, Fischer A, Suarez F, Francastel C, Picard C. Genetic, cellular and clinical features of ICF syndrome: a French national survey. J Clin Immunol. 2016;36:149–59.  https://doi.org/10.1007/s10875-016-0240-2.CrossRefPubMedGoogle Scholar
  5. van den Boogaard ML, Thijssen PE, Aytekin C, Licciardi F, Kıykım AA, Spossito L, Dalm VASH, Driessen GJ, Kersseboom R, de Vries FE, van Ostaijen-ten Dam MM, Ikinciogullari A, Dogu F, Oleastro M, Bailardo E, Daxinger L, Nain E, Baris S, van Tol MJD, Weemaes C, van der Maarel SM. Expanding the mutation spectrum in ICF syndrome: evidence for a gender bias in ICF2. Clin Genet. 2017;92:380–7.CrossRefGoogle Scholar
  6. Velasco G, Walton EL, Sterlin D, Hédouin S, Nitta H, Ito Y, Fouyssac F, Mégarbané A, Sasaki H, Picard C, Francastel C. Germline genes hypomethylation and expression define a molecular signature in peripheral blood of ICF patients: implications for diagnosis and etiology. Orphanet J Rare Dis. 2014;9:56.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Pediatric Hematology and Stem Cell Transplantation DepartmentSouth-Pest Central Hospital, United Szent Istvan and Szent Laszlo Hospital BudapestBudapestHungary

Section editors and affiliations

  • Jolan Walter
    • 1
  1. 1.USF HealthTampaUSA